FindTrial
Sign In

Application of quantitative analysis of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma in patients with liver cirrhosis

Application of quantitative analysis of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma in patients with liver cirrhosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020443
Enrollment
Unknown
Registered
2018-12-29
Start date
2018-07-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Hepatocellular Carcinoma

Interventions

Gold Standard:Pathological biopsy results
Index test:Quantitative&#32
parameters&#32
of&#32
contrast-enhanced&#32
ultrasound:TIC,&#32
PI,&#32
AUWI,&#32
AUWO,&#32
TPI&#32
and&#32
SWI.

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Small nodules and suspicious HCC were found in hepatic parenchyma by imaging examination, and the diameter of the nodule range from 1.0 cm to 3.0 cm; 2. Before the CEUS examination, no interventional or chemotherapy treatment was received; 3. There was no allergic reaction to SonoVue; 4. Willing to receive liver biopsy or surgical treatment; 5. Volunteer to participate in the experiment and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Diffuse primary hepatocellular carcinoma; 2. The focus is close to the heart, which is not good for CEUS image observers.

Design outcomes

Primary

MeasureTime frame
TIC;PI;AUWI;AUWO;TPI;SWI;—

Countries

China

Contacts

Public ContactMeng Fankun

Beijing Youan Hospital, Capital Medical University

mengfankun818@126.com+86 13811565771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026